·     About      ·     Presentations     ·   Speakers  ·    Agenda    ·    App    ·


8th annual Canadian Hematology Conference


Plasma Cell Dyscrasias / Chair: Dr. Peter Anglin

Relapsed Myeloma in 2018

Upfront Treatment of Myeloma in 2018


Non-Hodgkin’s Lymphoma / Chair: Dr. Michael Crump

CAR-T in Aggressive Lymphoma

Second Line Therapy of DLBCL – Choices?

Indolent Lymphoma – Re-visiting Chemo-free Therapy

Hodgkin’s Lymphoma / Chair: Dr. John Kuruvilla

How to Treat Advanced HL in 2018

RR HL – Where Does Therapy Go?

The Evolving Role of Radiation in HL

Chronic Lymphocytic Leukemia (CLL) / Chair: Dr. Graeme Fraser

Update on First Line Management on CLL

Relapsed CLL in 2018

Canadian Perspective Discussion Period

Non-Hodgkin’s Lymphoma II / Chair: Dr. David Macdonald

Waldenstrom Macroglobulinemia – New Standards for Therapy

Anti-CD20 in 2018

Challenges in the Management of Mantle Cell Lymphoma

Myeloproliferative Neoplasms (MPNs) and Leukemia / Chair: Dr. Dennis Kim

Practical Issues in CML in 2018



Thrombosis Session I / Chair: Dr. Wendy Lim

Current Treatment of Thromboembolism in 2018

Update on Recent Practice-Changing Clinical Trials in Thrombosis

Management of Anticoagulant Associated Bleeding

Non Malignant Hematological Disorders/ Chair: Dr. Denis Soulières

Cell Therapy for Non Malignant Hematological Disorders

Update on Sickle Cell

Evaluating Organ Iron Overload in Hematological Disorders

Thrombosis Session II / Chair: Dr. Wendy Lim

VTE in Pregnancy